Accueil   Diary - News   All news Adocia informs about a civil action filed by Eli Lilly

Adocia informs about a civil action filed by Eli Lilly

Lyon, France, October 11th, 2018 – 6:00 pm CET - ADOCIA (Euronext Paris: FR0011184241 – ADOC) the biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of approved proteins, announces that Eli Lilly and Company (“Lilly”) filed a complaint against Adocia in the United States District Court of the Southern District of Indiana on October 9th, 2018. Lilly’s complaint seeks a declaratory judgment that “the designations of inventorship currently appearing on [Lilly’s] United States Patent Nos. 9,901,623 and 9,993,555 are complete and correct, as required by the patent laws of the United States.”

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree